Related Experiment Video
Updated: Sep 9, 2025
08:19
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.0K
Liver Metastases License Neutrophils through IL1 to Potentiate Cancer Progression
Ashley N Pearson1, Jessica Waninger2, Amanda K Huber3
1Graduate Program in Immunology, University of Michigan, Ann Arbor, Michigan.
Cancer Immunology Research
|September 4, 2025
Summary
Liver metastases worsen cancer progression by suppressing antitumor immunity. This study reveals that liver metastases enhance neutrophil activity, promoting further tumor spread via IL-1 signaling, impacting patient outcomes.
Area of Science:
- Oncology
- Immunology
- Cancer Metastasis
Background:
- Liver metastases are linked to poor outcomes in solid tumors.
- Mechanisms by which liver metastases suppress anti-tumor immunity are not fully understood.
Purpose of the Study:
- To investigate how liver metastases influence cancer progression and systemic immunity.
- To elucidate the role of neutrophils in liver metastasis-driven disease progression.
Main Methods:
- Analysis of patient data for disease trajectory.
- Utilized multiple murine models of liver metastasis.
- Investigated neutrophil migration, activity, and IL-1 dependency.
Main Results:
- Liver metastases accelerate disease progression across various cancer types.
- Liver metastases increase neutrophil migration and activity in preclinical models.
- Neutrophils, activated by liver metastasis, promote further colonization in an IL-1 dependent manner.
Conclusions:
- Liver metastases reprogram systemic immunity to foster cancer progression.
- Understanding these immune changes is crucial for developing new therapeutic strategies.
- Targeting neutrophil activity could offer a novel approach to combat liver metastasis.
Related Concept Videos
02:30Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K